Advertisement
Screener

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Accumulated Other Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

TEVA PHARMACEUTICAL INDUSTRIES LIMITED Accumulated Other Comprehensive Income

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Accumulated Other Comprehensive Income of -$2.46 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-29

  • 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.46B.
  • 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.51B.
  • 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.39B.
  • 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.48B.
Period endAccumulated Other Comprehensive Income (Loss), Net of Tax
2026-06-30-$2.46B
10-Q · filed 2026-07-29
2026-03-31-$2.51B
10-Q · filed 2026-04-29
2025-12-31-$2.39B
10-Q · filed 2026-07-29
2025-09-30-$2.48B
10-Q · filed 2025-11-05
2025-06-30-$2.43B
10-Q · filed 2025-07-30
2025-03-31-$2.67B
10-Q · filed 2025-05-07
2024-12-31-$3.15B
10-K · filed 2026-02-03
2024-09-30-$2.77B
10-Q · filed 2024-11-06
2024-06-30-$2.88B
10-Q · filed 2024-07-31
2024-03-31-$2.77B
10-Q · filed 2024-05-08
2023-12-31-$2.70B
10-K · filed 2025-02-05
2023-09-30-$2.91B
10-Q · filed 2023-11-09
2023-06-30-$2.68B
10-Q · filed 2023-08-02
2023-03-31-$2.70B
10-Q · filed 2023-05-10
2022-12-31-$2.84B
10-K · filed 2024-02-12
2022-09-30-$3.15B
10-Q · filed 2022-11-03
2022-06-30-$2.80B
10-Q · filed 2022-07-27
2022-03-31-$2.69B
10-Q · filed 2022-05-03
2021-12-31-$2.68B
10-K · filed 2023-02-10
2021-09-30-$2.62B
10-Q · filed 2021-10-27
2021-06-30-$2.45B
10-Q · filed 2021-07-28
2021-03-31-$2.53B
10-Q · filed 2021-04-28
2020-12-31-$2.40B
10-K · filed 2022-02-09
2020-09-30-$2.64B
10-Q · filed 2020-11-05
2020-06-30-$2.70B
10-Q · filed 2020-08-05
2020-03-31-$2.85B
10-Q · filed 2020-05-07
2019-12-31-$2.31B
10-K · filed 2021-02-10
2019-09-30-$2.37B
10-Q · filed 2019-11-07
2019-06-30-$2.31B
10-Q · filed 2019-08-07
2019-03-31-$2.36B
10-Q · filed 2019-05-02
2018-12-31-$2.46B
10-K · filed 2020-02-21
2018-09-30-$2.33B
10-Q · filed 2018-11-01
2018-06-30-$2.29B
10-Q · filed 2018-08-02
2018-03-31-$1.74B
10-Q · filed 2018-05-03
2017-12-31-$1.85B
10-K · filed 2019-02-19
2017-09-30-$2.20B
6-K · filed 2017-11-02
2017-06-30-$2.40B
6-K · filed 2017-08-03
2017-03-31-$2.71B
6-K · filed 2017-05-11
2016-12-31-$3.16B
10-K · filed 2018-02-12
2016-09-30-$2.71B
6-K · filed 2017-11-02
2016-06-30-$2.54B
6-K · filed 2017-08-03
2016-03-31-$2.24B
6-K · filed 2016-05-09
2015-12-31-$1.96B
10-K · filed 2018-02-12
2015-09-30-$2.14B
6-K · filed 2015-10-29
2015-06-30-$1.89B
6-K · filed 2015-07-30
2015-03-31-$1.92B
6-K · filed 2015-04-30
2014-12-31-$1.34B
10-K · filed 2018-02-12
2014-09-30-$836.00M
6-K · filed 2014-10-30
2014-06-30-$256.00M
6-K · filed 2014-07-31
2014-03-31-$247.00M
6-K · filed 2014-05-02
2013-12-31-$91.00M
20-F · filed 2017-02-15
2013-09-30-$157.00M
6-K · filed 2013-10-31
2013-06-30-$454.00M
6-K · filed 2013-08-01
2013-03-31-$251.00M
6-K · filed 2013-05-02
2012-12-31-$17.00M
20-F · filed 2015-02-09
2012-09-30-$233.00M
6-K · filed 2012-11-01
2012-06-30-$684.00M
6-K · filed 2012-08-02
2012-03-31$142.00M
6-K · filed 2012-05-09
2011-12-31-$589.00M
20-F · filed 2014-02-10
2011-09-30$286.00M
6-K · filed 2011-11-02
2011-06-30$1.56B
6-K · filed 2011-07-28
2011-03-31$1.26B
6-K · filed 2011-05-11
2010-12-31$350.00M
20-F · filed 2013-02-12
2010-09-30$639.00M
6-K · filed 2010-11-02
2010-06-30-$779.00M
6-K · filed 2010-07-27
2010-03-31$280.00M
6-K · filed 2010-05-04
2009-12-31$555.00M
20-F · filed 2011-02-15
2009-09-30$977.00M
6-K · filed 2009-11-03
2009-06-30$290.00M
6-K · filed 2009-07-29
2009-03-31-$288.00M
6-K · filed 2009-05-07
2008-12-31$390.00M
20-F · filed 2010-02-22